vs
Pediatrix Medical Group, Inc.（MD）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
RANGE RESOURCES CORP的季度营收约是Pediatrix Medical Group, Inc.的1.6倍（$786.9M vs $493.8M），RANGE RESOURCES CORP净利率更高（22.8% vs 6.8%，领先15.9%），RANGE RESOURCES CORP同比增速更快（18.0% vs -1.7%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
MD vs RRC — 直观对比
营收规模更大
RRC
是对方的1.6倍
$493.8M
营收增速更快
RRC
高出19.7%
-1.7%
净利率更高
RRC
高出15.9%
6.8%
两年增速更快
RRC
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $786.9M |
| 净利润 | $33.7M | $179.1M |
| 毛利率 | — | 94.5% |
| 营业利润率 | 9.9% | — |
| 净利率 | 6.8% | 22.8% |
| 营收同比 | -1.7% | 18.0% |
| 净利润同比 | 10.5% | 88.8% |
| 每股收益（稀释后） | $0.40 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDRRC
| Q4 25 | $493.8M | $786.9M | ||
| Q3 25 | $492.9M | $655.3M | ||
| Q2 25 | $468.8M | $699.6M | ||
| Q1 25 | $458.4M | $846.3M | ||
| Q4 24 | $502.4M | $667.0M | ||
| Q3 24 | $511.2M | $567.9M | ||
| Q2 24 | $504.3M | $513.2M | ||
| Q1 24 | $495.1M | $598.8M |
净利润MDRRC
| Q4 25 | $33.7M | $179.1M | ||
| Q3 25 | $71.7M | $144.3M | ||
| Q2 25 | $39.3M | $237.6M | ||
| Q1 25 | $20.7M | $97.1M | ||
| Q4 24 | $30.5M | $94.8M | ||
| Q3 24 | $19.4M | $50.7M | ||
| Q2 24 | $-153.0M | $28.7M | ||
| Q1 24 | $4.0M | $92.1M |
毛利率MDRRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | — | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
营业利润率MDRRC
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | -31.3% | — | ||
| Q1 24 | 3.2% | — |
净利率MDRRC
| Q4 25 | 6.8% | 22.8% | ||
| Q3 25 | 14.5% | 22.0% | ||
| Q2 25 | 8.4% | 34.0% | ||
| Q1 25 | 4.5% | 11.5% | ||
| Q4 24 | 6.1% | 14.2% | ||
| Q3 24 | 3.8% | 8.9% | ||
| Q2 24 | -30.3% | 5.6% | ||
| Q1 24 | 0.8% | 15.4% |
每股收益（稀释后）MDRRC
| Q4 25 | $0.40 | $0.75 | ||
| Q3 25 | $0.84 | $0.60 | ||
| Q2 25 | $0.46 | $0.99 | ||
| Q1 25 | $0.24 | $0.40 | ||
| Q4 24 | $0.37 | $0.38 | ||
| Q3 24 | $0.23 | $0.21 | ||
| Q2 24 | $-1.84 | $0.12 | ||
| Q1 24 | $0.05 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $204.0K |
| 总债务越低越好 | $570.5M | $1.2B |
| 股东权益账面价值 | $865.9M | $4.3B |
| 总资产 | $2.2B | $7.4B |
| 负债/权益比越低杠杆越低 | 0.66× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资MDRRC
| Q4 25 | $375.2M | $204.0K | ||
| Q3 25 | $340.1M | $175.0K | ||
| Q2 25 | $224.7M | $134.0K | ||
| Q1 25 | $99.0M | $344.6M | ||
| Q4 24 | $229.9M | $304.5M | ||
| Q3 24 | $103.8M | $277.4M | ||
| Q2 24 | $19.4M | $251.1M | ||
| Q1 24 | $8.0M | $343.1M |
总债务MDRRC
| Q4 25 | $570.5M | $1.2B | ||
| Q3 25 | $577.2M | $1.2B | ||
| Q2 25 | $583.9M | $1.2B | ||
| Q1 25 | $590.5M | $1.7B | ||
| Q4 24 | $597.1M | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益MDRRC
| Q4 25 | $865.9M | $4.3B | ||
| Q3 25 | $890.7M | $4.2B | ||
| Q2 25 | $833.8M | $4.1B | ||
| Q1 25 | $789.2M | $3.9B | ||
| Q4 24 | $764.9M | $3.9B | ||
| Q3 24 | $732.5M | $3.9B | ||
| Q2 24 | $706.5M | $3.9B | ||
| Q1 24 | $856.2M | $3.8B |
总资产MDRRC
| Q4 25 | $2.2B | $7.4B | ||
| Q3 25 | $2.2B | $7.2B | ||
| Q2 25 | $2.1B | $7.1B | ||
| Q1 25 | $2.0B | $7.4B | ||
| Q4 24 | $2.2B | $7.3B | ||
| Q3 24 | $2.1B | $7.2B | ||
| Q2 24 | $2.0B | $7.3B | ||
| Q1 24 | $2.2B | $7.4B |
负债/权益比MDRRC
| Q4 25 | 0.66× | 0.28× | ||
| Q3 25 | 0.65× | 0.29× | ||
| Q2 25 | 0.70× | 0.29× | ||
| Q1 25 | 0.75× | 0.43× | ||
| Q4 24 | 0.78× | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.39× | 1.44× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDRRC
| Q4 25 | $114.1M | $257.5M | ||
| Q3 25 | $137.3M | $247.5M | ||
| Q2 25 | $137.2M | $336.2M | ||
| Q1 25 | $-117.5M | $330.1M | ||
| Q4 24 | $133.0M | $217.9M | ||
| Q3 24 | $91.8M | $245.9M | ||
| Q2 24 | $107.0M | $148.8M | ||
| Q1 24 | $-125.2M | $331.9M |
现金转化率MDRRC
| Q4 25 | 3.39× | 1.44× | ||
| Q3 25 | 1.91× | 1.72× | ||
| Q2 25 | 3.49× | 1.42× | ||
| Q1 25 | -5.66× | 3.40× | ||
| Q4 24 | 4.36× | 2.30× | ||
| Q3 24 | 4.72× | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | -31.03× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
